| Trial Acronym | EASI-SWITCH |
| Clinical Area | Cancer |
| Description | Interventional study comparing whether early switch to oral antibiotics 12-24 hours after intravenous antibiotic treatment commences in patients with low risk of neutropenic sepsis is non-inferior to standard care. This is a randomised, controlled, non-inferiority trial with allocation concealment. Both arms of the trial will be conducted in parallel. |
| Status | ANALYSIS AND REPORTING |
| Recruitment duration | 1st January 2020 |
| Target Recruitment | 628 |
| Recruitment to date | 129 |
| Trial Design | A multi-centre, interventional, randomised, controlled, non-inferiority trial with allocation concealment. |
| Study Aim | To establish the clinical and cost-effectiveness of early switch to oral antibiotics, 12-24 hours after intravenous antibiotic treatment commences in low risk cancer patients with neutropenic sepsis. |
| Chief Investigator | Dr Victoria Coyle & Dr Ronan McMullan |
| Sponsor | Belfast Health and Social Care Trust |
| Funder | National Institute for Health Research |